| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |